v.231201
Showing details for project SYSMHC00009
| SampleID | NumReplicates | Organism | TissueType | CellType | MHCAllele |
|---|---|---|---|---|---|
| SampleID | NumReplicates | Organism | TissueType | CellType | MHCAllele |
| SYSMHC00009_gradosd_140409_perreault-thibault_cada_LCL_M1 | 7 | Human | HLA-A03:01,HLA-A29:02,HLA-B08:01,HLA-B44:03,HLA-C07:01,HLA-C16:01 | ||
| SYSMHC00009_gradosd_140409_perreault-thibault_cada_LCL_M2 | 7 | Human | HLA-A03:01,HLA-A29:02,HLA-B08:01,HLA-B44:03,HLA-C07:01,HLA-C16:01 | ||
| SYSMHC00009_gradosd_140409_perreault-thibault_cada_LCL_M3 | 7 | Human | HLA-A03:01,HLA-A29:02,HLA-B08:01,HLA-B44:03,HLA-C07:01,HLA-C16:01 | ||
| SYSMHC00009_gradosd_140409_perreault-thibault_cada_LCL_M4 | 7 | Human | HLA-A03:01,HLA-A29:02,HLA-B08:01,HLA-B44:03,HLA-C07:01,HLA-C16:01 | ||
| SYSMHC00009_gradosd_140409_perreault-thibault_cada_LCL_R1 | 6 | Human | HLA-A03:01,HLA-A29:02,HLA-B08:01,HLA-B44:03,HLA-C07:01,HLA-C16:01 | ||
| SYSMHC00009_gradosd_140409_perreault-thibault_cada_LCL_R2 | 7 | Human | HLA-A03:01,HLA-A29:02,HLA-B08:01,HLA-B44:03,HLA-C07:01,HLA-C16:01 | ||
| SYSMHC00009_gradosd_140409_perreault-thibault_cada_LCL_R3 | 7 | Human | HLA-A03:01,HLA-A29:02,HLA-B08:01,HLA-B44:03,HLA-C07:01,HLA-C16:01 | ||
| SYSMHC00009_gradosd_140409_perreault-thibault_cada_LCL_R4 | 7 | Human | HLA-A03:01,HLA-A29:02,HLA-B08:01,HLA-B44:03,HLA-C07:01,HLA-C16:01 |
Detailed view of sample SYSMHC00009_gradosd_140409_perreault-thibault_cada_LCL_M3
| ID | SampleID | RawFileName | Organism | Process | Tissue Type | Cell Type | Culture Conditions | Disease State | Comments | MHCClass | MHCAllele | PubMed ID | Peptide | Isolation Method | Antibody | Mass Spectrometer | LC System | iRT Peptides | Acquisition Mode | Fragmentation Method | Gradient | Gradient Length | Flow Rate | Replicate Number |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ID | SampleID | RawFileName | Organism | Process | Tissue_Type | Cell_Type | Culture_Conditions | Disease_State | Comments | MHCClass | MHCAllele | PubMed_ID | Peptide | Isolation_Method | Antibody | Mass_Spectrometer | LC_System | iRT_Peptides | Acquisition_Mode | Fragmentation_Method | Gradient | Gradient_Length | Flow_Rate | Replicate_Number |
| SYSMHC00009 | SYSMHC00009_gradosd_140409_perreault-thibault_cada_LCL_M3 | SYSMHC00009_DS_M3_120629_F6.raw | Human | In vitro | Blood | Lymphoblast cell | suspension | EBV transformed | class I | HLA-A03:01,HLA-A29:02,HLA-B08:01,HLA-B44:03,HLA-C07:01,HLA-C16:01 | 24714562 | native | Mild acid elution | Orbitrap Elite | Eksigent LC system | no | DDA | CID | 3-60% | 120 | 6 nl min−1 | 1 | ||
| SYSMHC00009 | SYSMHC00009_gradosd_140409_perreault-thibault_cada_LCL_M3 | SYSMHC00009_DS_M3_120629_F5.raw | Human | In vitro | Blood | Lymphoblast cell | suspension | EBV transformed | class I | HLA-A03:01,HLA-A29:02,HLA-B08:01,HLA-B44:03,HLA-C07:01,HLA-C16:01 | 24714562 | native | Mild acid elution | Orbitrap Elite | Eksigent LC system | no | DDA | CID | 3-60% | 120 | 6 nl min−1 | 2 | ||
| SYSMHC00009 | SYSMHC00009_gradosd_140409_perreault-thibault_cada_LCL_M3 | SYSMHC00009_DS_M3_120629_F4.raw | Human | In vitro | Blood | Lymphoblast cell | suspension | EBV transformed | class I | HLA-A03:01,HLA-A29:02,HLA-B08:01,HLA-B44:03,HLA-C07:01,HLA-C16:01 | 24714562 | native | Mild acid elution | Orbitrap Elite | Eksigent LC system | no | DDA | CID | 3-60% | 120 | 6 nl min−1 | 3 | ||
| SYSMHC00009 | SYSMHC00009_gradosd_140409_perreault-thibault_cada_LCL_M3 | SYSMHC00009_DS_M3_120629_F7.raw | Human | In vitro | Blood | Lymphoblast cell | suspension | EBV transformed | class I | HLA-A03:01,HLA-A29:02,HLA-B08:01,HLA-B44:03,HLA-C07:01,HLA-C16:01 | 24714562 | native | Mild acid elution | Orbitrap Elite | Eksigent LC system | no | DDA | CID | 3-60% | 120 | 6 nl min−1 | 4 | ||
| SYSMHC00009 | SYSMHC00009_gradosd_140409_perreault-thibault_cada_LCL_M3 | SYSMHC00009_DS_M3_120629_F2.raw | Human | In vitro | Blood | Lymphoblast cell | suspension | EBV transformed | class I | HLA-A03:01,HLA-A29:02,HLA-B08:01,HLA-B44:03,HLA-C07:01,HLA-C16:01 | 24714562 | native | Mild acid elution | Orbitrap Elite | Eksigent LC system | no | DDA | CID | 3-60% | 120 | 6 nl min−1 | 5 | ||
| SYSMHC00009 | SYSMHC00009_gradosd_140409_perreault-thibault_cada_LCL_M3 | SYSMHC00009_DS_M3_120629_F1.raw | Human | In vitro | Blood | Lymphoblast cell | suspension | EBV transformed | class I | HLA-A03:01,HLA-A29:02,HLA-B08:01,HLA-B44:03,HLA-C07:01,HLA-C16:01 | 24714562 | native | Mild acid elution | Orbitrap Elite | Eksigent LC system | no | DDA | CID | 3-60% | 120 | 6 nl min−1 | 6 | ||
| SYSMHC00009 | SYSMHC00009_gradosd_140409_perreault-thibault_cada_LCL_M3 | SYSMHC00009_DS_M3_120629_F3.raw | Human | In vitro | Blood | Lymphoblast cell | suspension | EBV transformed | class I | HLA-A03:01,HLA-A29:02,HLA-B08:01,HLA-B44:03,HLA-C07:01,HLA-C16:01 | 24714562 | native | Mild acid elution | Orbitrap Elite | Eksigent LC system | no | DDA | CID | 3-60% | 120 | 6 nl min−1 | 7 |